Kirke  Weaver net worth and biography

Kirke Weaver Biography and Net Worth

General Counsel & Secretary of Organon & Co.

Kirke Weaver is the General Counsel and Corporate Secretary for Organon, serving as the senior legal adviser and responsible for the company’s worldwide legal affairs, compliance and global environmental, health and safety functions. He is focused on ensuring Organon maintains the highest ethical standards, which will help drive Organon’s achievement of its vision as a leading women’s healthcare company.

Prior to his appointment as General Counsel and Corporate Secretary, Kirke served as Senior Vice President, Commercial, Regulatory, Securities, Employment and Deputy Corporate Secretary at Organon. He was critical to launching Organon as a standalone company in June 2021, acting as a senior member of the legal leadership team.

Before joining Organon, Kirke was the Vice President for Regulatory Legal at Merck. Over his 18 year career at Merck, Kirke developed a deep expertise in the pharmaceutical industry and held positions of increasing responsibility counseling the business in areas such as litigation, regulatory, commercial, and compliance. Kirke also led the Customer Alliances & Innovation group to develop and commercialize new software tools to support medication adherence. Kirke holds a J.D. from the Yale Law School and a Bachelor of Arts in history and government from the College of William and Mary.

What is Kirke Weaver's net worth?

The estimated net worth of Kirke Weaver is at least $233,939.21 as of February 22nd, 2024. Mr. Weaver owns 15,181 shares of Organon & Co. stock worth more than $233,939 as of November 14th. This net worth evaluation does not reflect any other investments that Mr. Weaver may own. Learn More about Kirke Weaver's net worth.

How old is Kirke Weaver?

Mr. Weaver is currently 50 years old. There are 6 older executives and no younger executives at Organon & Co.. The oldest executive at Organon & Co. is Mr. Kevin Ali, CEO & Director, who is 64 years old. Learn More on Kirke Weaver's age.

How do I contact Kirke Weaver?

The corporate mailing address for Mr. Weaver and other Organon & Co. executives is 2000 Galloping Hill Road, Kenilworth, New Jersey 07033. Organon & Co. can also be reached via phone at 551-430-6900 and via email at [email protected]. Learn More on Kirke Weaver's contact information.

Has Kirke Weaver been buying or selling shares of Organon & Co.?

Kirke Weaver has not been actively trading shares of Organon & Co. during the last ninety days. Most recently, on Thursday, February 22nd, Kirke Weaver bought 2,720 shares of Organon & Co. stock. The stock was acquired at an average cost of $18.36 per share, with a total value of $49,939.20. Following the completion of the transaction, the insider now directly owns 15,181 shares of the company's stock, valued at $278,723.16. Learn More on Kirke Weaver's trading history.

Who are Organon & Co.'s active insiders?

Organon & Co.'s insider roster includes Ma. Francisco (Director), and Kirke Weaver (General Counsel & Secretary). Learn More on Organon & Co.'s active insiders.

Are insiders buying or selling shares of Organon & Co.?

During the last year, Organon & Co. insiders bought shares 1 times. They purchased a total of 2,720 shares worth more than $49,939.20. The most recent insider tranaction occured on February, 22nd when insider Kirke Weaver bought 2,720 shares worth more than $49,939.20. Insiders at Organon & Co. own 1.4% of the company. Learn More about insider trades at Organon & Co..

Information on this page was last updated on 2/22/2024.

Kirke Weaver Insider Trading History at Organon & Co.

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2024Buy2,720$18.36$49,939.2015,181View SEC Filing Icon  
See Full Table

Kirke Weaver Buying and Selling Activity at Organon & Co.

This chart shows Kirke Weaver's buying and selling at Organon & Co. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Organon & Co. Company Overview

Organon & Co. logo
Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.
Read More

Today's Range

Now: $15.41
Low: $15.36
High: $15.83

50 Day Range

MA: $18.37
Low: $15.58
High: $21.36

2 Week Range

Now: $15.41
Low: $10.84
High: $23.10

Volume

690,546 shs

Average Volume

2,243,616 shs

Market Capitalization

$3.97 billion

P/E Ratio

3.06

Dividend Yield

7.19%

Beta

0.84